Logo image of TERN

TERNS PHARMACEUTICALS INC (TERN) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:TERN - US8808811074 - Common Stock

47.09 USD
+2.48 (+5.56%)
Last: 12/11/2025, 8:09:23 PM
47.09 USD
0 (0%)
After Hours: 12/11/2025, 8:09:23 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
TERN revenue by date.TERN revenue by date.
1M
-100.00%
3.281M55.783M
1,600.18%
247.88M
344.36%
277.46M
11.93%
589.77M
112.56%
EBITDA
YoY % growth
TERN ebitda by date.TERN ebitda by date.
-70M
-280.64%
-36.64M
47.66%
-49.35M
-34.69%
-64.25M
-24.72%
-104.478M
-66.15%
-105.06M
0.70%
-112.742M
-11.02%
-139.406M
-23.65%
-167.76M
-20.34%
-182.07M
-8.53%
-124.542M
31.60%
113.93M
191.48%
251.63M
120.86%
733.99M
191.69%
EBIT
YoY % growth
TERN ebit by date.TERN ebit by date.
-70.2M
-280.28%
-37.03M
47.25%
-49.86M
-34.65%
-64.802M
-24.41%
-135.246M
-65.34%
-105.442M
0.67%
-114.352M
-12.25%
-135.893M
-18.84%
-158.021M
-16.28%
-174.357M
-10.34%
-200.212M
-14.83%
-71.667M
64.20%
77.533M
208.18%
338.33M
336.37%
Operating Margin
TERN operating margin by date.TERN operating margin by date.
N/AN/A-4,986.00%N/AN/AN/AN/AN/AN/A-5,314.16%-358.91%-28.91%27.94%57.37%
EPS
YoY % growth
TERN eps by date.TERN eps by date.
N/AN/A-2.34
28.53%
-1.92
21.79%
-1.36
30.60%
-1.23
11.02%
-1.10
2.50%
-1.34
-21.75%
-1.57
-17.33%
-1.63
-3.70%
-1.36
16.88%
-0.77
43.61%
-0.04
94.23%
1.84
4,264.67%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28
EPS
Q2Q % growth
-0.31
-27.50%
-0.31
-18.35%
-0.33
-25.54%
-0.35
-29.08%
-0.38
-24.78%
-0.35
-12.71%
-0.35
-6.25%
-0.37
-5.36%
-0.39
-1.51%
-0.40
-14.71%
-0.40
-14.71%
Revenue
Q2Q % growth
N/AN/AN/AN/AN/AN/A
EBITDA
Q2Q % growth
-30.206M
-17.86%
-32.354M
-18.20%
-32.509M
-19.01%
-32.708M
-18.35%
N/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-30.55M
-17.73%
-33.15M
-20.87%
-34.2M
-24.90%
-35.369M
-27.61%
-52.122M
-70.61%
N/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.27
3.57%
-0.300.0310.70%
Q2 2025
Q2Q % growth
-0.26
16.13%
-0.300.0412.10%
Q1 2025
Q2Q % growth
-0.26
13.33%
-0.290.038.96%
Q4 2024
Q2Q % growth
-0.24
17.24%
-0.320.0824.07%
Q3 2024
Q2Q % growth
-0.28
33.33%
-0.330.0514.33%
Q2 2024
Q2Q % growth
-0.31
-24.00%
-0.350.0410.61%
Q1 2024
Q2Q % growth
-0.30
3.23%
-0.340.0412.85%
Q4 2023
Q2Q % growth
-0.29 -0.300.012.71%
Q3 2023
Q2Q % growth
-0.42
4.55%
-0.31-0.11-34.76%
Q2 2023
Q2Q % growth
-0.25
54.55%
-0.350.1027.68%
Q1 2023
Q2Q % growth
-0.31
43.64%
-0.27-0.04-13.53%
Q4 2022
Q2Q % growth
-0.29
48.21%
-0.440.1533.88%
Q3 2022
Q2Q % growth
-0.44
6.38%
-0.530.0917.04%
Q2 2022
Q2Q % growth
-0.55
-27.91%
-0.610.069.12%
Q1 2022
Q2Q % growth
-0.55
37.50%
-0.660.1116.18%
Q4 2021
Q2Q % growth
-0.56
98.19%
-0.640.0812.39%
Q3 2021
Q2Q % growth
-0.47 -0.620.1523.63%
Q2 2021
Q2Q % growth
-0.43 -0.720.2940.62%
Q1 2021
Q2Q % growth
-0.88 -0.79-0.09-11.56%
Q4 2020
Q2Q % growth
-30.94 -0.93-30.01-3,233.33%
TERN Yearly EPS VS EstimatesTERN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 -2 -3
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth

-100.00%
%
TERN Yearly Revenue VS EstimatesTERN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS1.15% 1.55% 4.22% 2.7%
RevenueN/A N/A N/A N/A